Latest Breaking News On - Porton advanced - Page 1 : comparemela.com

Week In Review: BeiGene Signs $1 3B Deal For Preclinical CDK2 Inhibitor From Boston s Ensem

Week In Review: BeiGene Signs $1 3B Deal For Preclinical CDK2 Inhibitor From Boston s Ensem
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diegoBiopharma hong kongHaisco pharmaSimcere biopharmaUsynova biopharmaChiesi farmaceuticiMyricx bioAbstract molecularEnsem therapeuticsGreater chinaConnect biopharmaConnect biopharma hong kongSuzhou connectShanghai based wuxi biologics

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoHong kongMenlo parkLerna biopharmaZhuhai biotheusTrinity innovation fundChina phaseWuxi apptecWuxi biologicsSenti biosciencesHuagai capitalTrinity innovationPorton advancedLarge language modelsAdeno associated virus

Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development

Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Yangzhou wangRobin liWei liuPorton advanced solutionsPorton pharma solutions ltdGene therapy developmentPorton advanced announcesa strategic partnershipAdvanced announcesStrategic partnershipGene therapyPorton advancedAdeno associated virusSenior vice presidentPharma solutionsCell therapeuticsQuality management

Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy

/PRNewswire/ Porton Advanced Solutions Ltd. (Porton Advanced) and DanausGT Biotechnology Co., Ltd. (DanausGT) announced on February 27, 2023, a strategic.

United statesWang haifengWang yangzhouJose carlos segoviaPorton advanced solutionsDanausgt biotechnology co ltdPorton pharma solutions ltdClinical phaseProfessor jose carlos segoviaVivo gene editingDefinitive curePorton advancedPharma solutionsCell therapeuticsQuality management

Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform

/PRNewswire/ On February 20, 2023, Porton Advanced Solutions Ltd. (Porton Advanced) and Yinjia (Shanghai) Biosciences Co., Ltd. (Yinjia Biosciences).

Yinjia biosciencesWang yangzhouWu yifeiPorton advanced solutionsYinjia shanghai biosciences co ltdPorton advanced solutions ltdPorton pharma solutions ltdPorton advancedPharma solutionsCell therapeuticsQuality management